Clascoterone Cream 1% in Acne Management: Case Series and Real-World Canadian Experience

    March 2025 in “ Canadian dermatology today. ”
    Wei Jing Loo
    Studysummary In this case series, treatment with clascoterone cream 1% was reported to be effective and well tolerated for diverse acne vulgaris patients, improving clinical outcomes whether used alone or in combination with other therapies, and addressing various other skin conditions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on canadiandermatologytoday.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Guidelines of Care for the Management of Acne Vulgaris Journal of the American Academy of Dermatology · 2024
    2. Use of Topical Clascoterone for the Treatment of Hidradenitis Suppurativa JAAD Case Reports · 2023
    3. Clascoterone as a Novel Treatment for Androgenetic Alopecia Clinical and Experimental Dermatology · 2020
    4. A Summary of In Vitro, Phase I, and Phase II Studies Evaluating the Mechanism of Action, Safety, and Efficacy of Clascoterone (Cortexolone 17a Propionate, CB-03-01) in Androgenetic Alopecia Journal of The American Academy of Dermatology · 2019